From hyperglycemia to intervertebral disc damage: exploring diabetic-induced disc degeneration
- PMID: 38444852
- PMCID: PMC10912372
- DOI: 10.3389/fimmu.2024.1355503
From hyperglycemia to intervertebral disc damage: exploring diabetic-induced disc degeneration
Abstract
The incidence of lumbar disc herniation has gradually increased in recent years, and most patients have symptoms of low back pain and nerve compression, which brings a heavy burden to patients and society alike. Although the causes of disc herniation are complex, intervertebral disc degeneration (IDD) is considered to be the most common factor. The intervertebral disc (IVD) is composed of the upper and lower cartilage endplates, nucleus pulposus, and annulus fibrosus. Aging, abnormal mechanical stress load, and metabolic disorders can exacerbate the progression of IDD. Among them, high glucose and high-fat diets (HFD) can lead to fat accumulation, abnormal glucose metabolism, and inflammation, which are considered important factors affecting the homeostasis of IDD. Diabetes and advanced glycation end products (AGEs) accumulation- can lead to various adverse effects on the IVD, including cell senescence, apoptosis, pyroptosis, proliferation, and Extracellular matrix (ECM) degradation. While current research provides a fundamental basis for the treatment of high glucose-induced IDD patients. further exploration into the mechanisms of abnormal glucose metabolism affecting IDD and in the development of targeted drugs will provide the foundation for the effective treatment of these patients. We aimed to systematically review studies regarding the effects of hyperglycemia on the progress of IDD.
Keywords: AGEs; Intervertebral disc degeneration; annulus fibrosus; cartilage endplates; high glucose; nucleus pulposus.
Copyright © 2024 Li, Du, Huang, Gao, Zhao, Chang, Zhang and He.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Treatment of Intervertebral Disc Degeneration.Orthop Surg. 2022 Jul;14(7):1271-1280. doi: 10.1111/os.13254. Epub 2022 Apr 29. Orthop Surg. 2022. PMID: 35486489 Free PMC article. Review.
-
Role of Advanced Glycation End Products in Intervertebral Disc Degeneration: Mechanism and Therapeutic Potential.Oxid Med Cell Longev. 2022 Dec 17;2022:7299005. doi: 10.1155/2022/7299005. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 36573114 Free PMC article. Review.
-
The Mechanism and Function of miRNA in Intervertebral Disc Degeneration.Orthop Surg. 2022 Mar;14(3):463-471. doi: 10.1111/os.13204. Epub 2022 Feb 9. Orthop Surg. 2022. PMID: 35142050 Free PMC article. Review.
-
Role of autophagy in intervertebral disc degeneration.J Cell Physiol. 2022 Feb;237(2):1266-1284. doi: 10.1002/jcp.30631. Epub 2021 Nov 17. J Cell Physiol. 2022. PMID: 34787318 Free PMC article. Review.
-
Ginsenoside Rg1 inhibits nucleus pulposus cell apoptosis, inflammation and extracellular matrix degradation via the YAP1/TAZ pathway in rats with intervertebral disc degeneration.J Orthop Surg Res. 2022 Dec 20;17(1):555. doi: 10.1186/s13018-022-03443-4. J Orthop Surg Res. 2022. PMID: 36539815 Free PMC article.
Cited by
-
"Dictionary of immune responses" reveals the critical role of monocytes and the core target IRF7 in intervertebral disc degeneration.Front Immunol. 2024 Oct 17;15:1465126. doi: 10.3389/fimmu.2024.1465126. eCollection 2024. Front Immunol. 2024. PMID: 39483476 Free PMC article.
-
Effect of type 2 diabetes mellitus on patients undergoing percutaneous endoscopic lumbar discectomy: a retrospective propensity score-matched cohort study.Eur Spine J. 2025 Jun;34(6):2321-2328. doi: 10.1007/s00586-025-08808-x. Epub 2025 Mar 29. Eur Spine J. 2025. PMID: 40155440
-
Targeting advanced glycation end products: potential therapeutic approaches for mitigating diabetic intervertebral disc degeneration?Front Endocrinol (Lausanne). 2025 Jul 7;16:1618984. doi: 10.3389/fendo.2025.1618984. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40692599 Free PMC article. Review.
-
Apoptotic Pathway in Intervertebral Disc Degeneration: From Molecular Pathways to Clinical Interventions.Diagnostics (Basel). 2025 Jun 13;15(12):1510. doi: 10.3390/diagnostics15121510. Diagnostics (Basel). 2025. PMID: 40564831 Free PMC article. Review.
-
Natural products for intervertebral disc degeneration: mechanistic insights and therapeutic potentials.Front Pharmacol. 2025 Jul 25;16:1605764. doi: 10.3389/fphar.2025.1605764. eCollection 2025. Front Pharmacol. 2025. PMID: 40786036 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical